Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.
作者信息
Papa Stella M, Brundin Patrik, Fung Victor S C, Kang Un Jung, Burn David J, Colosimo Carlo, Chiang Han-Lin, Alcalay Roy N, Trenkwalder Claudia
机构信息
Yerkes National Primate Research Center, Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
Van Andel Institute, Center for Neurodegenerative Science, Grand Rapids, Michigan, USA.
出版信息
Mov Disord. 2020 May;35(5):711-715. doi: 10.1002/mds.28067. Epub 2020 Apr 16.
Abstract
摘要
相似文献
1
Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.2019年冠状病毒病大流行对帕金森病和运动障碍的影响
Mov Disord. 2020 May;35(5):711-715. doi: 10.1002/mds.28067. Epub 2020 Apr 16.
2
Movement Disorders in the World of COVID-19.新冠疫情下的运动障碍
Mov Disord. 2020 May;35(5):709-710. doi: 10.1002/mds.28069. Epub 2020 Apr 16.
3
Secondary Impact of the COVID-19 Pandemic on Patients With Heart Failure.新冠疫情对心力衰竭患者的继发性影响。
Circ Heart Fail. 2020 May;13(5):e007219. doi: 10.1161/CIRCHEARTFAILURE.120.007219. Epub 2020 Apr 30.
4
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19.大流行中的疫情：阿片类药物使用障碍和 COVID-19。
Ann Intern Med. 2020 Jul 7;173(1):57-58. doi: 10.7326/M20-1141. Epub 2020 Apr 2.
5
Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson's Disease During the COVID-19 Pandemic: New Expectations for the Future.在2019冠状病毒病大流行期间为帕金森病患者提供紧急和持续医疗保健的远程医疗实施：对未来的新期望
J Parkinsons Dis. 2020;10(3):911-913. doi: 10.3233/JPD-202108.
6
Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.心力衰竭协作实验室关于 COVID-19 背景下临床试验的声明。
JACC Heart Fail. 2020 May;8(5):423-425. doi: 10.1016/j.jchf.2020.03.005. Epub 2020 Mar 27.
7
Rethinking Clinical Trials Reform During the COVID-19 Pandemic.新冠疫情期间对临床试验改革的反思
JAMA Oncol. 2020 Sep 1;6(9):1327-1329. doi: 10.1001/jamaoncol.2020.3142.
8
Covid-19: The last call for telepsychiatry.新冠疫情：远程精神病学的最后呼吁。
Acta Biomed. 2020 Jul 28;91(3):ahead of print. doi: 10.23750/abm.v91i3.10337.
9
E-Rehabilitation: One solution for patients with Parkinson's disease in COVID-19 era.电子康复：新冠疫情时代帕金森病患者的一种解决方案。
Parkinsonism Relat Disord. 2020 Jun;75:128-129. doi: 10.1016/j.parkreldis.2020.05.021. Epub 2020 Jun 4.
10
What can Parkinson's disease teach us about COVID-19?帕金森病能让我们对新冠病毒有哪些了解？
Neurol Neurochir Pol. 2020;54(2):204-206. doi: 10.5603/PJNNS.a2020.0039. Epub 2020 Apr 23.
引用本文的文献
1
Online training program maintains motor functions and quality of life in patients with Parkinson's disease.在线培训项目可维持帕金森病患者的运动功能和生活质量。
Front Digit Health. 2024 Nov 13;6:1486662. doi: 10.3389/fdgth.2024.1486662. eCollection 2024.
2
COVID-19 related neurological manifestations in Parkinson's disease: has ferroptosis been a suspect?帕金森病中与COVID-19相关的神经表现：铁死亡是可疑因素吗？
Cell Death Discov. 2024 Mar 19;10(1):146. doi: 10.1038/s41420-024-01915-6.
3
Telehealth For Individuals with Parkinson's Disease During Covid-19 In Brazil: A Prospective Case Series.巴西新冠疫情期间帕金森病患者的远程医疗：一项前瞻性病例系列研究
Int J Telerehabil. 2022 Dec 13;14(2):e6471. doi: 10.5195/ijt.2022.6471. eCollection 2022.
4
COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection.新冠病毒与神经系统疾病：帕金森病与新冠病毒感染之间可能存在何种关联。
Front Neurol. 2023 May 18;14:1172416. doi: 10.3389/fneur.2023.1172416. eCollection 2023.
5
Feasibility for evaluating motor aspects of Parkinson's disease through video consultations in a resource-limited setting in Southern Brazil.在巴西南部资源有限的环境下，通过视频咨询评估帕金森病运动方面的可行性。
Arq Neuropsiquiatr. 2023 May;81(5):444-451. doi: 10.1055/s-0043-1768665. Epub 2023 May 31.
6
The Role of Telemedicine in the Treatment of Cognitive and Psychological Disorders in Parkinson's Disease: An Overview.远程医疗在帕金森病认知和心理障碍治疗中的作用：综述
Brain Sci. 2023 Mar 16;13(3):499. doi: 10.3390/brainsci13030499.
7
Feasibility of telemedicine for patients with parkinsonism in the Brazilian public health system.远程医疗在巴西公共卫生系统中用于帕金森病患者的可行性。
Arq Neuropsiquiatr. 2022 Sep;80(9):914-921. doi: 10.1055/s-0042-1755323. Epub 2022 Oct 4.
8
Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease.新冠疫情对帕金森病患者的社会隔离、孤独感和心理健康后遗症的影响。
Int Rev Neurobiol. 2022;165:197-227. doi: 10.1016/bs.irn.2022.03.003. Epub 2022 Apr 23.
9
Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies.新冠病毒与帕金森病：护理、疫苗接种及对先进疗法的影响。
Int Rev Neurobiol. 2022;165:173-196. doi: 10.1016/bs.irn.2022.04.005. Epub 2022 Jul 9.
10
The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations.统一多系统萎缩评定量表：现状、批评与建议。
Mov Disord. 2022 Dec;37(12):2336-2341. doi: 10.1002/mds.29215. Epub 2022 Sep 8.
本文引用的文献
1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Can we contain the COVID-19 outbreak with the same measures as for SARS?我们能否用应对 SARS 的相同措施来控制 COVID-19 疫情？
Lancet Infect Dis. 2020 May;20(5):e102-e107. doi: 10.1016/S1473-3099(20)30129-8. Epub 2020 Mar 5.
3
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.全长人血管紧张素转化酶 2 识别 SARS-CoV-2 的结构基础。
Science. 2020 Mar 27;367(6485):1444-1448. doi: 10.1126/science.abb2762. Epub 2020 Mar 4.
4
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒：将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Viral load of SARS-CoV-2 in clinical samples.临床样本中新型冠状病毒2的病毒载量
Lancet Infect Dis. 2020 Apr;20(4):411-412. doi: 10.1016/S1473-3099(20)30113-4. Epub 2020 Feb 24.
7
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.SARS-CoV2 的神经侵袭性可能在 COVID-19 患者的呼吸衰竭中起作用。
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
8
Presumed Asymptomatic Carrier Transmission of COVID-19.新冠病毒无症状感染者的传播。
JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.
9
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.
10
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.感染患者上呼吸道标本中的新型冠状病毒2型病毒载量
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
Zotero 插件